BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23664862)

  • 1. G13 controls angiogenesis through regulation of VEGFR-2 expression.
    Sivaraj KK; Takefuji M; Schmidt I; Adams RH; Offermanns S; Wettschureck N
    Dev Cell; 2013 May; 25(4):427-34. PubMed ID: 23664862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
    Assareh E; Mehrnejad F; Mansouri K; Esmaeili Rastaghi AR; Naderi-Manesh H; Asghari SM
    Biochem J; 2019 Feb; 476(4):645-663. PubMed ID: 30700502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
    Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
    Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
    Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population.
    Grimm M; Tischner D; Troidl K; Albarrán Juárez J; Sivaraj KK; Ferreirós Bouzas N; Geisslinger G; Binder CJ; Wettschureck N
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):37-48. PubMed ID: 26603156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
    Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
    J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
    Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
    Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC; Fleischmann A; Waser B; Rehmann R
    Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis.
    Salvati E; Zizza P; Rizzo A; Iachettini S; Cingolani C; D'Angelo C; Porru M; Randazzo A; Pagano B; Novellino E; Pisanu ME; Stoppacciaro A; Spinella F; Bagnato A; Gilson E; Leonetti C; Biroccio A
    Nucleic Acids Res; 2014 Mar; 42(5):2945-57. PubMed ID: 24335081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity.
    Kempf A; Tews B; Arzt ME; Weinmann O; Obermair FJ; Pernet V; Zagrebelsky M; Delekate A; Iobbi C; Zemmar A; Ristic Z; Gullo M; Spies P; Dodd D; Gygax D; Korte M; Schwab ME
    PLoS Biol; 2014 Jan; 12(1):e1001763. PubMed ID: 24453941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
    Shih SC; Ju M; Liu N; Smith LE
    J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNAI1, an endothelial-mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization.
    Sun JX; Chang TF; Li MH; Sun LJ; Yan XC; Yang ZY; Liu Y; Xu WQ; Lv Y; Su JB; Liang L; Han H; Dou GR; Wang YS
    Angiogenesis; 2018 Aug; 21(3):635-652. PubMed ID: 29675549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase D up-regulates transcription of
    Wang Y; Hoeppner LH; Angom RS; Wang E; Dutta S; Doeppler HR; Wang F; Shen T; Scarisbrick IA; Guha S; Storz P; Bhattacharya R; Mukhopadhyay D
    J Biol Chem; 2019 Oct; 294(43):15759-15767. PubMed ID: 31492751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
    Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
    J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.